{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:21:49Z","timestamp":1790256109534,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,17]]},"DOI":"10.7759\/cureus.58470","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:40:34Z","timestamp":1713354034000},"source":"Crossref","is-referenced-by-count":21,"title":["The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates"],"prefix":"10.7759","author":[{"given":"Parth  R","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyanendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarang","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushang","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pathology and genetics. Tumours of the urinary system and male genital organs","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Pathology and genetics. Tumours of the urinary system and male genital organs. Eble JN, Sauter G, Epstein JI, et al. (ed): IARC Press, Lyon; 2004. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Pathology-And-Genetics-Of-Tumours-O...."},{"key":"ref2","article-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs.","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. WHO Classification of Tumours of the Urinary System and Male Genital Organs.. Moch H, Humphrey PA, Ulbright TM, Reuter VE (ed): IARC Press, Lyon; 2016. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Tumours-Of-Th...."},{"key":"ref3","article-title":"Urinary and Male Genital Tumours","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA (ed): IARC Press, Lyon; 2022. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Urinary-And-Male-Genital-Tumours-2022."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.057","article-title":"Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal","volume":"173","author":"Turajlic S","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, et al.. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell. 2018, 173:581-594.E12. 10.1016\/j.cell.2018.03.057","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov K","year":"2021","unstructured":"Trpkov K, Hes O, Williamson SR, et al.. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021, 34:1392-1424. 10.1038\/s41379-021-00779-w","journal-title":"Mod Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-818","article-title":"What's new in the WHO 2022 classification of kidney tumours?","volume":"115","author":"Alaghehbandan R","year":"2022","unstructured":"Alaghehbandan R, Siadat F, Trpkov K. What's new in the WHO 2022 classification of kidney tumours?. Pathologica. 2022, 115:8-22. 10.32074\/1591-951X-818","journal-title":"Pathologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001422","article-title":"\u201cRenal cell carcinoma with leiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, mTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah RB","year":"2020","unstructured":"Shah RB, Stohr BA, Tu ZJ, et al.. \u201cRenal cell carcinoma with leiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, mTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity. Am J Surg Pathol. 2020, 44:571-581. 10.1097\/PAS.0000000000001422","journal-title":"Am J Surg Pathol"},{"key":"ref8","article-title":"Eosinophilic solid and cystic renal cell carcinoma","author":"Argani P","year":"2022","unstructured":"Argani P, Hartmann A, Hes O, Magi-Galluzzi C, McKenney JK, Trpkov K. Eosinophilic solid and cystic renal cell carcinoma. WHO Classification of the Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA editors (ed): IARC Press, Lyon; 2022. 69-70."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ gcc.20839","article-title":"ALK rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Mari\u00f1o-Enr\u00edquez A","year":"2011","unstructured":"Mari\u00f1o-Enr\u00edquez A, Ou WB, Weldon CB, Fletcher JA, P\u00e9rez-Atayde AR. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011, 50:146-153. 10.1002\/ gcc.20839","journal-title":"Genes Chromosomes Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.05.051","article-title":"BRAF mutations in metanephric adenoma of the kidney","volume":"62","author":"Choueiri TK","year":"2012","unstructured":"Choueiri TK, Cheville J, Palescandolo E, et al.. BRAF mutations in metanephric adenoma of the kidney. Eur Urol. 2012, 62:917-922. 10.1016\/j.eururo.2012.05.051","journal-title":"Eur Urol"},{"key":"ref11","article-title":"Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors","volume":"10","author":"Delahunt B","year":"1997","unstructured":"Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997, 10:537-544.","journal-title":"Mod Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan WM","year":"2016","unstructured":"Linehan WM, Spellman PT, Ricketts CJ, et al.. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016, 374:135-145. 10.1056\/NEJMoa1505917","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy KI","year":"2019","unstructured":"Al-Obaidy KI, Eble JN, Cheng L, et al.. Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol. 2019, 43:1099-1111. 10.1097\/PAS.0000000000001288","journal-title":"Am J Surg Pathol"},{"key":"ref14","article-title":"Papillary renal cell carcinoma","author":"Williamson S","year":"2022","unstructured":"Williamson S, Hartmann A, Hes O, Martignoni G, Rioux-Leclercq NO, Saleeb RM. Papillary renal cell carcinoma. WHO Classification of the Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA (ed): IARC Press, Lyon; 2022. 47-49."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001467","article-title":"Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations","volume":"44","author":"Argani P","year":"2020","unstructured":"Argani P, Reuter VE, Eble JN, et al.. Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations. Am J Surg Pathol. 2020, 44:901-916. 10.1097\/PAS.0000000000001467","journal-title":"Am J Surg Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000639","article-title":"Biphasic squamoid alveolar renal cell carcinoma: a distinctive subtype of papillary renal cell carcinoma?","volume":"40","author":"Hes O","year":"2016","unstructured":"Hes O, Mundo EC, Peckova K, et al.. Biphasic squamoid alveolar renal cell carcinoma: a distinctive subtype of papillary renal cell carcinoma?. Am J Surg Pathol. 2016, 40:664-675. 10.1097\/PAS.0000000000000639","journal-title":"Am J Surg Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00223-3","article-title":"Primary thyroid like carcinoma of the kidney","volume":"48","author":"Angell SK","year":"1996","unstructured":"Angell SK, Pruthi R, Freiha FS. Primary thyroid like carcinoma of the kidney. Urology. 1996, 48:632-635. 10.1016\/S0090-4295(96)00223-3","journal-title":"Urology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001846","article-title":"NF2-mutated renal carcinomas have common morphologic features which overlap with biphasic hyalinizing psammomatous renal cell carcinoma: a comprehensive study of 14 cases","volume":"46","author":"Paintal A","year":"2022","unstructured":"Paintal A, Tjota MY, Wang P, et al.. NF2-mutated renal carcinomas have common morphologic features which overlap with biphasic hyalinizing psammomatous renal cell carcinoma: a comprehensive study of 14 cases. Am J Surg Pathol. 2022, 46:617-627. 10.1097\/PAS.0000000000001846","journal-title":"Am J Surg Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00833-7","article-title":"EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma","volume":"34","author":"Al-Obaidy KI","year":"2021","unstructured":"Al-Obaidy KI, Bridge JA, Cheng L, et al.. EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Mod Pathol. 2021, 34:1921-1934. 10.1038\/s41379-021-00833-7","journal-title":"Mod Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo SK","year":"2006","unstructured":"Tickoo SK, dePeralta-Venturina MN, Harik LR, et al.. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006, 30:141-153. 10.1097\/01.pas.0000185382.80844.b1","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318164bcbb","article-title":"Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity","volume":"32","author":"Gobbo S","year":"2008","unstructured":"Gobbo S, Eble JN, Grignon DJ, et al.. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008, 32:1239-1245. 10.1097\/PAS.0b013e318164bcbb","journal-title":"Am J Surg Pathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.10.007","article-title":"Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology","volume":"61","author":"Brannon AR","year":"2012","unstructured":"Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, Rathmell WK. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol. 2012, 61:258-268. 10.1016\/j.eururo.2011.10.007","journal-title":"Eur Urol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181f2ee0b","article-title":"Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney","volume":"34","author":"Aydin H","year":"2010","unstructured":"Aydin H, Chen L, Cheng L, et al.. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010, 34:1608-1621. 10.1097\/PAS.0b013e3181f2ee0b","journal-title":"Am J Surg Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith SC","year":"2016","unstructured":"Smith SC, Trpkov K, Chen YB, et al.. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol. 2016, 40:1457-1472. 10.1097\/PAS.0000000000000719","journal-title":"Am J Surg Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov K","year":"2016","unstructured":"Trpkov K, Hes O, Agaimy A, et al.. Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol. 2016, 40:865-875. 10.1097\/PAS.0000000000000617","journal-title":"Am J Surg Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/his.13183","article-title":"A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","volume":"71","author":"Smith SC","year":"2017","unstructured":"Smith SC, Sirohi D, Ohe C, et al.. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma. Histopathology. 2017, 71:42-52. 10.1111\/his.13183","journal-title":"Histopathology"},{"key":"ref27","article-title":"Fumarate hydratase-deficient renal cell carcinoma","author":"Hes O","year":"2022","unstructured":"Hes O, Gill A, Gupta S, Jimenez RE, Smith SC, Trpkov K. Fumarate hydratase-deficient renal cell carcinoma. WHO Classification of the Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA (ed): IARC Press, Lyon; 2022. 78-79."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.09.027","article-title":"Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas","volume":"69","author":"Calderaro J","year":"2016","unstructured":"Calderaro J, Masliah-Planchon J, Richer W, et al.. Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas. Eur Urol. 2016, 69:1055-1061. 10.1016\/j.eururo.2015.09.027","journal-title":"Eur Urol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0273-1","article-title":"Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases","volume":"32","author":"Jia L","year":"2019","unstructured":"Jia L, Carlo MI, Khan H, et al.. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases. Mod Pathol. 2019, 32:1329-1343. 10.1038\/s41379-019-0273-1","journal-title":"Mod Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.44","article-title":"Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior","volume":"21","author":"Cheng JX","year":"2008","unstructured":"Cheng JX, Tretiakova M, Gong C, Mandal S, Krausz T, Taxy JB. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008, 21:647-652. 10.1038\/modpathol.2008.44","journal-title":"Mod Pathol"},{"key":"ref31","article-title":"SMARCB1-deficient renal medullary carcinoma","author":"Argani P","year":"2022","unstructured":"Argani P, Agaimy A, Colombo P, et al.. SMARCB1-deficient renal medullary carcinoma. WHO Classification of the Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA (ed): IARC Press, Lyon; 2022. 84-86."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.195.1.7892499","article-title":"Renal medullary carcinoma associated with sickle cell trait: radiologic findings","volume":"195","author":"Davidson AJ","year":"1995","unstructured":"Davidson AJ, Choyke PL, Hartman DS, Davis CJ Jr. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology. 1995, 195:83-85. 10.1148\/radiology.195.1.7892499","journal-title":"Radiology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-016-0551-x","article-title":"An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report","volume":"11","author":"Yu L","year":"2016","unstructured":"Yu L, Li J, Xu S, Miranda MN, Wang G, Duan Y. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Diagn Pathol. 2016, 11:98. 10.1186\/s13000-016-0551-x","journal-title":"Diagn Pathol"},{"key":"ref34","article-title":"TFEB-altered renal cell carcinomas","author":"Argani P","year":"2022","unstructured":"Argani P, Martignoni G, Rao Q. TFEB-altered renal cell carcinomas. WHO Classification of the Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA (ed): IARC Press, Lyon; 2022. 74-75."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani P","year":"2001","unstructured":"Argani P, Antonescu CR, Illei PB, et al.. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001, 159:179-192. 10.1016\/S0002-9440(10)61684-7","journal-title":"Am J Pathol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani P","year":"2001","unstructured":"Argani P, Hawkins A, Griffin CA, et al.. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol. 2001, 158:2089-2096. 10.1016\/S0002-9440(10)64680-9","journal-title":"Am J Pathol"},{"key":"ref37","article-title":"TFE3-rearranged renal cell carcinomas","author":"Argani P","year":"2022","unstructured":"Argani P, Martignoni G, Mehra R, Yu WJ. TFE3-rearranged renal cell carcinomas. WHO Classification of the Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA (ed): IARC Press, Lyon; 2022. 72-73."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00713-6","article-title":"TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1","volume":"34","author":"Cali\u00f2 A","year":"2021","unstructured":"Cali\u00f2 A, Harada S, Brunelli M, et al.. TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1. Mod Pathol. 2021, 34:842-850. 10.1038\/s41379-020-00713-6","journal-title":"Mod Pathol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001408","article-title":"Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCS): expanding the genomic spectrum","volume":"44","author":"Xia QY","year":"2020","unstructured":"Xia QY, Wang XT, Fang R, et al.. Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCS): expanding the genomic spectrum. Am J Surg Pathol. 2020, 44:477-489. 10.1097\/PAS.0000000000001408","journal-title":"Am J Surg Pathol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000332","article-title":"Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities","volume":"29","author":"Tretiakova MS","year":"2022","unstructured":"Tretiakova MS. Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities. Adv Anat Pathol. 2022, 29:131-140. 10.1097\/PAP.0000000000000332","journal-title":"Adv Anat Pathol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","volume":"31","author":"Skala SL","year":"2018","unstructured":"Skala SL, Xiao H, Udager AM, et al.. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Mod Pathol. 2018, 31:179-197. 10.1038\/modpathol.2017.99","journal-title":"Mod Pathol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck S","year":"2015","unstructured":"Durinck S, Stawiski EW, Pav\u00eda-Jim\u00e9nez A, et al.. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet. 2015, 47:13-21. 10.1038\/ng.3146","journal-title":"Nat Genet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas Harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove DN","year":"2018","unstructured":"Palsgrove DN, Li Y, Pratilas CA, et al.. Eosinophilic solid and cystic (ESC) renal cell carcinomas Harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum. Am J Surg Pathol. 2018, 42:1166-1181. 10.1097\/PAS.0000000000001111","journal-title":"Am J Surg Pathol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/his.13395","article-title":"Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients","volume":"72","author":"Li Y","year":"2018","unstructured":"Li Y, Reuter VE, Matoso A, Netto GJ, Epstein JI, Argani P. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients. Histopathology. 2018, 72:588-600. 10.1111\/his.13395","journal-title":"Histopathology"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo J","year":"2014","unstructured":"Guo J, Tretiakova MS, Troxell ML, et al.. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol. 2014, 38:1457-1467. 10.1097\/PAS.0000000000000248","journal-title":"Am J Surg Pathol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov K","year":"2017","unstructured":"Trpkov K, Abou-Ouf H, Hes O, et al.. Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity. Am J Surg Pathol. 2017, 41:1299-1308. 10.1097\/PAS.0000000000000838","journal-title":"Am J Surg Pathol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/his.13457","article-title":"Eosinophilic solid and cystic renal cell carcinomas have metastatic potential","volume":"72","author":"McKenney JK","year":"2018","unstructured":"McKenney JK, Przybycin CG, Trpkov K, Magi-Galluzzi C. Eosinophilic solid and cystic renal cell carcinomas have metastatic potential. Histopathology. 2018, 72:1066-1067. 10.1111\/his.13457","journal-title":"Histopathology"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20839","article-title":"ALK rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Mari\u00f1o-Enr\u00edquez A","year":"2011","unstructured":"Mari\u00f1o-Enr\u00edquez A, Ou WB, Weldon CB, Fletcher JA, P\u00e9rez-Atayde AR. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011, 50:146-153. 10.1002\/gcc.20839","journal-title":"Genes Chromosomes Cancer"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.213","article-title":"Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum","volume":"24","author":"Debelenko LV","year":"2011","unstructured":"Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol. 2011, 24:430-442. 10.1038\/modpathol.2010.213","journal-title":"Mod Pathol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.03.032","article-title":"Responses to alectinib in ALK-rearranged papillary renal cell carcinoma","volume":"74","author":"Pal SK","year":"2018","unstructured":"Pal SK, Bergerot P, Dizman N, et al.. Responses to alectinib in ALK-rearranged papillary renal cell carcinoma. Eur Urol. 2018, 74:124-128. 10.1016\/j.eururo.2018.03.032","journal-title":"Eur Urol"},{"key":"ref51","article-title":"ELOC (formerly TCEB1)-mutated renal cell carcinoma","author":"Argani P","year":"2022","unstructured":"Argani P, Martignoni G, McKenney J, Tickoo SK. ELOC (formerly TCEB1)-mutated renal cell carcinoma. WHO Classification of the Urinary and Male Genital Tumours. Cree IA, Levy GG, Lokuhetty D, Rao BV, White VA (ed): IARC Press, Lyon; 2022. 76-77."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi AA","year":"2015","unstructured":"Hakimi AA, Tickoo SK, Jacobsen A, et al.. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype. Mod Pathol. 2015, 28:845-853. 10.1038\/modpathol.2015.6","journal-title":"Mod Pathol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?","volume":"75","author":"Trpkov K","year":"2019","unstructured":"Trpkov K, Williamson SR, Gao Y, et al.. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?. Histopathology. 2019, 75:174-184. 10.1111\/his.13865","journal-title":"Histopathology"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2021.04.013","article-title":"Low-grade oncocytic tumor of kidney (CK7-positive, CD117-negative): incidence in a single institutional experience with clinicopathological and molecular characteristics","volume":"114","author":"Kravtsov O","year":"2021","unstructured":"Kravtsov O, Gupta S, Cheville JC, et al.. Low-grade oncocytic tumor of kidney (CK7-positive, CD117-negative): incidence in a single institutional experience with clinicopathological and molecular characteristics. Hum Pathol. 2021, 114:9-18. 10.1016\/j.humpath.2021.04.013","journal-title":"Hum Pathol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01057-z","article-title":"Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities","volume":"35","author":"Hes O","year":"2022","unstructured":"Hes O, Trpkov K. Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities. Mod Pathol. 2022, 35:1140-1150. 10.1038\/s41379-022-01057-z","journal-title":"Mod Pathol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2021-207478","article-title":"Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute","volume":"75","author":"Akgul M","year":"2022","unstructured":"Akgul M, Al-Obaidy KI, Cheng L, Idrees MT. Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute. J Clin Pathol. 2022, 75:772-775. 10.1136\/jclinpath-2021-207478","journal-title":"J Clin Pathol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/his.14816","article-title":"Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity","volume":"82","author":"Williamson SR","year":"2023","unstructured":"Williamson SR, Hes O, Trpkov K, et al.. Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity. Histopathology. 2023, 82:296-304. 10.1111\/his.14816","journal-title":"Histopathology"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: three-letter acronyms of emerging renal entities knocking on the door of the WHO classification","volume":"12","author":"Siadat F","year":"2020","unstructured":"Siadat F, Trpkov K. ESC, ALK, HOT and LOT: three-letter acronyms of emerging renal entities knocking on the door of the WHO classification. Cancers (Basel). 2020, 12:10.3390\/cancers12010168","journal-title":"Cancers (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000299","article-title":"Eosinophilic vacuolated tumor of the kidney: a review of evolving concepts in this novel subtype with additional insights from a case with mTOR mutation and concomitant chromosome 1 loss","volume":"28","author":"Kapur P","year":"2021","unstructured":"Kapur P, Gao M, Zhong H, et al.. Eosinophilic vacuolated tumor of the kidney: a review of evolving concepts in this novel subtype with additional insights from a case with mTOR mutation and concomitant chromosome 1 loss. Adv Anat Pathol. 2021, 28:251-257. 10.1097\/PAP.0000000000000299","journal-title":"Adv Anat Pathol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.11.004","article-title":"Renal neoplasia in tuberous sclerosis: a study of 41 patients","volume":"96","author":"Gupta S","year":"2021","unstructured":"Gupta S, Jimenez RE, Herrera-Hernandez L, et al.. Renal neoplasia in tuberous sclerosis: a study of 41 patients. Mayo Clin Proc. 2021, 96:1470-1489. 10.1016\/j.mayocp.2020.11.004","journal-title":"Mayo Clin Proc"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00923-6","article-title":"Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases","volume":"35","author":"Farca\u015f M","year":"2022","unstructured":"Farca\u015f M, Gatalica Z, Trpkov K, et al.. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. Mod Pathol. 2022, 35:344-351. 10.1038\/s41379-021-00923-6","journal-title":"Mod Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/237567-the-who-2022-classification-of-renal-neoplasms-5th-edition-salient-updates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:40:37Z","timestamp":1713354037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/237567-the-who-2022-classification-of-renal-neoplasms-5th-edition-salient-updates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.58470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}